Anxiety Disorders Depression Treatment Market In-Depth Analysis, Industry Status, Growth Analysis And Forecast Till 2025 : Grand View Research Inc.

08/apr/2019 12:38:25 Grand View Research Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

San Francisco, 8 April 2019:  The Report  Anxiety Disorders And Depression Treatment Market  Analysis By Product (Antidepressant Drugs, SSRIs, SNRIs, Benzodiazepines, Devices And Therapy, TMS, DBS, VBS), By Indication (MDD, OCD, Phobia), And Segment Forecasts, 2018 - 2025

The global Anxiety Disorders Depression Treatment Market is expected to reach USD 18.3 billion by 2025. The rising incidence of depression is anticipated to drive growth in the coming years. Increased adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in the recent years.

The rising geriatric population prone to depression and surging preven- tion of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing towards the growing demand for mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies using medical-based applications, furnish patients with innovative treatment alternatives.

Access Research Report of  Anxiety Disorders Depression Treatment  Market  www.grandviewresearch.com/industry-analysis/anxiety-disorders-and-depression-treatment-market

Further key findings from the study suggest:

  • Presently, the antidepressant drugs segment holds the largest revenue share. However, two to the rising occurrence of adverse events associated with these therapeutics, this segment is expected to wane
  • Patent expiration of branded medicines and introduction of generic biosimilars, which are cost effective, are responsible for the shrinking market of antidepressants
  • On the other hand, introduction of new medicines, such as Duloxetine, Fetzima, and Brintellix, are predicted to fuel the demand for therapeutics in the coming years 
  • Furthermore, the personalized therapies and devices segmented
  • Cognitive behavioral therapy held in the majority share in 2015
  • Transcranial Magnetic Stimulation (TMS) is predicted to witness lucrative growth two to the introduction of technologically advanced devices such as MagVita TMS Therapy System by MagVenture in July 2015 and Brainsway Deep TMS in January 2013
  • North American regional segment anxiety disorders and depression treatment reached a saturation level
  • Pfizer, Inc .; Eli Lilly and Company; GlaxoSmithKline plc; AstraZeneca; and H. Lundbeck A / S captured a sizable share in 2015 and accounted for more than 60% of the antidepressant drugs vertical
  • The revenue captured by antidepressants is expected to decrease with generic dominating the market during the forecast period

Browse more reports of this category by Grand View Research at:  www.grandviewresearch.com/industry/pharmaceuticals

Research has segmented the anxiety disorders and depression treatment market by product, indication, and region:

Anxiety Disorder and Depression Treatment Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Antidepressant drugs
    • SSRIs
    • SNRIs
    • TCAs
    • MAOIs
    • Atypical Antipsychotics
    • benzodiazepines
    • anticonvulsants
    • Beta-Blockers
    • Others
  • Therapy & Devices
    • Fischer Wallace Stimulator
    • TMS
    • DBS
    • VNS
    • ECT
    • CBT
    • Others

Anxiety Disorder and Depression Treatment Indication Outlook (Revenue, USD Million, 2014 - 2025)

  • MDD
  • OCD
  • phobias
  • Others

Anxiety Disorder and Regional Depression Treatment (Revenue, USD Million, 2014 - 2025)

  • North America
  • europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Access Press Release of  Anxiety Disorders Depression Treatment  Market  www.grandviewresearch.com/press-release/global-anxiety-disorders-and-depression-treatment-market

About Grand View Research

Grand View Research, Inc. is a US based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies relevant and fact-based research across a range of industries, from chemicals to chemicals, materials and healthcare.

For More Information:  www.grandviewresearch.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl